Download

Full Text

• DM Nathan JB Buse MB Davidson 2009 Medical management of hyperglycaemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia 52 17 30
• DM Nathan JB Buse MB Davidson 2006 Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia 49 1711 1721 (Pubitemid 44025023)
• DM Nathan JB Buse MB Davidson 2008 Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones Diabetologia 51 8 11 (Pubitemid 50004100)
• RM Lago PP Singh RW Nesto 2007 Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials Lancet 370 1129 1136 (Pubitemid 47464583)
• JO Friedrich J Beyene NKJ Adhikari 2009 Rosiglitazone: can meta-analysis accurately estimate excess cardiovascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches BMC Research Notes 2 5
• D Geng D Jin W Wei 2009 Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials Atherosclerosis 202 521 528
• The Action to Control Cardiovascular Risk in Diabetes Study Group 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545 2559
• W Duckworth C Abraira T Moritz 2009 Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 129 139
• Gever J (2008) ADA: VA Diabetes Trial appears to vindicate rosiglitazone (Avandia) safety. Available from http://www.medpage today.com/MeetingCoverage/ ADA/9749, accessed 1 March 2009
• SE Kahn SM Haffner MA Heise for the ADOPT Study Group 2006 Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy N Engl J Med 355 2427 2443 (Pubitemid 44903747)
• PD Home SJ Pocock H Beck-Nielsen 2007 Rosiglitazone evaluated for cardiovascular outcomes-an interim analysis N Engl J Med 357 28 38 (Pubitemid 47026732)
• AJ Scheen 2008 Exenatide once weekly in type 2 diabetes Lancet 372 1197 1198
• MG Goldner GL Knatterud TE Prout 1971 Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results JAMA 218 1400 1410
• D Luft RM Schmülling M Eggstein 1978 Lactic acidosis in biguanide-treated diabetics: a review of 330 cases Diabetologia 14 75 87 (Pubitemid 8277514)